Veterinary Hypertonic Saline Solution 7.2%, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for parenteral administration. It contains no antimicrobial agents. Discard unused portion.
Veterinary Hypertonic saline solutions 7.2%, USP has value as a source of water, electrolytes and calories.
For use in replacement therapy of sodium, chloride and water which may become depleted in many diseases.
This product contains no preservatives. Use entire contents when first opened. Discard any unused solution.
The parenteral administration of Veterinary Hypertonic saline solution 7.2%, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states, or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injection.
In patients with diminished renal function, administration of Veterinary Hypertonic saline solution 7.2%, USP may result in sodium retention.
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.
Caution must be exercised in the administration of Veterinary HYPERTONIC SALINE SOLUTION 7.2%, USP to patients receiving corticosteroids or corticotropin. Do not administer unless solution is clear, and seal is intact.
Warm to body temperature and administer slowly by intravenous or subcutaneous injection. The amount and rate of administration must be judged by the veterinarian in relation to the condition being treated and the clinical response of the animal, being careful to avoid overhydration.
In an event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures.
See Warnings, Adverse Reactions and Precautions.
HYPERTONIC SALINE SOLUTION 7.2%, USP is supplied in plastic bags as follows:
NDC | Volume |
17033-502-01 | 1000 mL |
Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored in the moisture barrier overwrap at room temperature of (15°C - 30°C) OR (59°F - 86°F). Keep out of reach of children.
Tear overwrap downside at slit and remove solution bag. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as sterility may be impaired. If supplemental medication is desired, follow directions below.
WARNING: Additives may be incompatible.
Federal law (U.S.A.) restricts this drug to use by or on the order of a licensed veterinarian.